BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38081733)

  • 1. Anti-SRP-positive necrotising myopathy concurrent with breast malignancy.
    Dandasena T; Ingle V; Singhai A; Saigal S
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38081733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-Mediated Necrotizing Myopathy.
    Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
    Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in muscle magnetic resonance imaging findings between anti-signal recognition particle antibody-positive myopathy and anti-aminoacyl-tRNA synthetase antibody-positive myositis.
    Kimura M; Aizawa A; Kudou R; Rikitake Y; Iwao C; Rikitake M; Iwao K; Kariya Y; Kawaguchi T; Matsuda M; Miyauchi S; Takajo I; Umekita K
    Clin Exp Rheumatol; 2024 Feb; 42(2):321-328. PubMed ID: 37497714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.
    Valiyil R; Casciola-Rosen L; Hong G; Mammen A; Christopher-Stine L
    Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1328-34. PubMed ID: 20506493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
    Allenbach Y; Benveniste O; Stenzel W; Boyer O
    Nat Rev Rheumatol; 2020 Dec; 16(12):689-701. PubMed ID: 33093664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature.
    Cui BB; Tian YR; Ma XY; Yin G; Xie Q
    Front Immunol; 2021; 12():777502. PubMed ID: 34925350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic microangiopathy in a patient with anti-signal recognition particle antibody-positive immune-mediated necrotizing myopathy.
    Sakai K; Takahashi M; Ito Y; Yamada S; Ito T; Higuchi Y; Kameda S
    Int J Rheum Dis; 2024 Jan; 27(1):e14942. PubMed ID: 37828793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab therapy in necrotizing autoimmune myopathy associated with anti-SRP antibody: A clinical case review.
    Nóvoa Medina FJ; Gutiérrez Martínez J; González González Y; Romero Díaz B; Machín García S; Rosas Romero A
    Reumatol Clin (Engl Ed); 2018; 14(6):379-381. PubMed ID: 28389200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-signal recognition particle positive necrotizing myopathy-sjogren's syndrome overlap syndrome: a descriptive study on clinical and myopathology features.
    Xu L; Yang MG; Hu L; Gao H; Ji S
    BMC Musculoskelet Disord; 2023 Mar; 24(1):219. PubMed ID: 36959614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-SRP immune-mediated necrotizing myopathy: A critical review of current concepts.
    Ma X; Bu BT
    Front Immunol; 2022; 13():1019972. PubMed ID: 36311711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.
    Pinal-Fernandez I; Casal-Dominguez M; Carrino JA; Lahouti AH; Basharat P; Albayda J; Paik JJ; Ahlawat S; Danoff SK; Lloyd TE; Mammen AL; Christopher-Stine L
    Ann Rheum Dis; 2017 Apr; 76(4):681-687. PubMed ID: 27651398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-SRP immune-mediated necrotizing myopathy responsive to ofatumumab: a case report.
    Chen S; Yang J; He D; Fu J; Lai X; Zhao B; Chen X; Shang H
    Front Immunol; 2023; 14():1301109. PubMed ID: 38169756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature.
    Binns EL; Moraitis E; Maillard S; Tansley S; McHugh N; Jacques TS; Wedderburn LR; Pilkington C; Yasin SA; Nistala K;
    Pediatr Rheumatol Online J; 2017 Oct; 15(1):77. PubMed ID: 29089059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza A (H3N2) infection followed by anti-signal recognition particle antibody-positive necrotizing myopathy: A case report.
    Iriki J; Yamamoto K; Senju H; Nagaoka A; Yoshida M; Iwasaki K; Ashizawa N; Hirayama T; Tashiro M; Takazono T; Imamura Y; Miyazaki T; Izumikawa K; Yanagihara K; Tsujino A; Fukuoka J; Uetani M; Satoh M; Mukae H
    Int J Infect Dis; 2021 Feb; 103():33-36. PubMed ID: 33217572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Mediated Necrotizing Myopathy: Where do we Stand?
    Mohammed AGA; Gcelu A; Moosajee F; Botha S; Kalla AA
    Curr Rheumatol Rev; 2019; 15(1):23-26. PubMed ID: 29623846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of anti-SRP antibody-positive immune-mediated necrotizing myopathy triggered by human parvovirus B19 infection].
    Suzuki I; Nakao R; Unai Y; Miyazaki Y
    Rinsho Shinkeigaku; 2022 May; 62(5):363-368. PubMed ID: 35474284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-mediated necrotising myopathy in asymptomatic patients with high creatine kinase.
    Soares IFZ; Comprido VF; Hsu BRRHS; Alves de Siqueira Carvalho A
    BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33033004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.
    Basharat P; Christopher-Stine L
    Curr Rheumatol Rep; 2015 Dec; 17(12):72. PubMed ID: 26515574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid Arthritis Associated With Anti-Signal Recognition Particle Immune-Mediated Necrotizing Myopathy: A Case Report.
    Belkhribchia MR; Lobrinus JA; Semlil L; Chauveau N; Ajrinija A; Egervari K; Ennhaili ZE
    J Investig Med High Impact Case Rep; 2024; 12():23247096241231646. PubMed ID: 38353222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.